Mitogenic Properties of Insulin-Like Growth Factors I and II, Insulin-Like Growth Factor Binding Protein-3 and Epidermal Growth Factor on Human Breast Epithelial Cells in Primary Culture
- 1 October 2002
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 75 (3) , 203-212
- https://doi.org/10.1023/a:1019915101457
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancerClinical Endocrinology, 2000
- Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trialThe Lancet, 1998
- Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised womenThe Lancet, 1998
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- Insulin-like Growth Factor Binding Protein-3 Induces Apoptosis in MCF7 Breast Cancer CellsBiochemical and Biophysical Research Communications, 1997
- Estradiol and Antiestrogens Regulate a Growth Inhibitory Insulin-like Growth Factor Binding Protein 3 Autocrine Loop in Human Breast Cancer CellsJournal of Biological Chemistry, 1996
- Insulin‐like growth‐factor‐binding protein 3 is decreased in early‐stage operable pre‐menopausal breast cancerInternational Journal of Cancer, 1995
- Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancerEuropean Journal Of Cancer, 1993
- The insulin-like growth factor family of ligands, receptors, and binding proteinsBreast Cancer Research and Treatment, 1992
- Effect of Tamoxifen on Serum Insulinlike Growth Factor I Levels in Stage I Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1990